Maintenance
Also known as: Maintenances
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB05039 | Indacaterol | An inhaled long-acting beta-2 adrenergic agonist used to relax bronchial smooth muscle and improve symptoms and airflow obstruction caused by Chronic Obstructive Pulmonary Disease (COPD) and moderate to severe asthma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB05039 | Indacaterol | Beta-2 adrenergic receptor | target |
| DB05039 | Indacaterol | Cytochrome P450 3A4 | enzyme |
| DB05039 | Indacaterol | UDP-glucuronosyltransferase 1-1 | enzyme |
| DB05039 | Indacaterol | P-glycoprotein 1 | transporter |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB15765 | Sintilimab | 2 | Unknown Status | 1 |
| DB09570 | Ixazomib | Not Available | Not Yet Recruiting | 1 |
| DB00480 | Lenalidomide | Not Available | Not Yet Recruiting | 1 |